Back to @PierreKory's profile

Pierre Kory, MD MPA engagement report

@PierreKory - 612K followers on X

Measured over 5 original posts from a 30-day window, last computed on August 26, 2026.

Engagement

Per follower
0.236%
of 612K followers
Per impression
2.47%
59K views on a typical post
Reach
9.57%
of its followers see a post
Typical post
1.4K
interactions (median)
Saved
0.838%
491 bookmarks on a typical post
Posting rate
0.3/day
active 20% of days
Peak time
02:00 UTC
Thursday

Early reading. We have captured 5 original posts for this account, below the 8 we require before treating a median as settled. The numbers above describe what we have seen so far, not a finished profile of the account.

A typical post picks up 1.4K interactions against 612K followers, an engagement rate of 0.236%. Posts are seen about 59K times each, and 2.47% of those impressions turn into an interaction. That is about 9.57% of the follower count, which is the gap between an audience on paper and an audience in a timeline. Posting runs at about 0.3 posts a day over the last 30 days, though only 20% of days saw any activity at all. Most posts go out around 02:00 UTC, and Thursday is the busiest day of the week. Of the 5 posts sampled, 40% carry an image or video and 60% link out. The account's strongest tracked post pulled 44K interactions, about 30x its own typical post. Only 5 original posts have been captured so far, fewer than the 8 posts we want behind a median before treating it as settled. Read the figures above as an early measurement of this account, not as a finished profile of it.

Measured over 5 original posts from a 30-day window, last computed on August 26, 2026.

Where this sits in the catalog

At 0.236%, Pierre Kory, MD MPA sits above the 50th percentile of the 36,852 accounts in this comparison. That places it in the above the median band, which runs 0.08% to 0.435%.

p100.002%
p250.012%
p50 (median)0.08%
p750.435%
p902.10%
p99159.8%
Engagement rate as a share of followers, across the 36,852 accounts we have scanned enough to measure. The axis is logarithmic, because the top and bottom of this population are about 106,564 times apart and a linear axis would flatten everything below the median into a single point.
Show the percentile table
Engagement rate percentiles
PercentileEngagement rate
10th percentile0.002%
25th percentile0.012%
50th percentile0.08%
75th percentile0.435%
90th percentile2.10%
99th percentile159.8%

This ruler is the whole measured catalog, not a size-matched group: it shows where the raw rate falls across every account we can measure, all of which are large. For a like-for-like comparison, read the size-band percentile above instead. See how the bands are built

Posting timing

This account posts most often around 02:00 UTC, and Thursday is its busiest day of the week. The bars below are the catalog-wide pattern, with this account's own busiest slot marked. They do not show how this account performs at each hour: we keep one aggregate per account, not one per hour, so that measurement does not exist in our data.

Engagement by hour posted, UTCTwenty-four bars, one per UTC hour. Each bar shows how posts published in that hour compare with their own authors' median engagement. Bars above the centre line ran higher than the median, bars below ran lower. A marker flags Busiest hour: 02:00 UTC.
0003060912151821
Above the authors' own mediansBelowScale: plus or minus 6%Busiest hour: 02:00 UTC
Show engagement by hour posted, utc as a table
Engagement by hour posted, UTC
Hour (UTC)Vs author medianPosts
00:00 UTC-1%51K
01:00 UTC-2%52K
02:00 UTC-3%50K
03:00 UTC-4%54K
04:00 UTC-6%43K
05:00 UTC-4%42K
06:00 UTC-4%48K
07:00 UTC-5%52K
08:00 UTC-4%61K
09:00 UTC-3%70K
10:00 UTC-2%72K
11:00 UTC-3%79K
12:00 UTC-2%87K
13:00 UTC-3%95K
14:00 UTC-4%98K
15:00 UTC-2%101K
16:00 UTC-4%99K
17:00 UTC-2%91K
18:00 UTC-1%85K
19:00 UTC-1%80K
20:00 UTC-1%75K
21:00 UTC-1%66K
22:00 UTC-2%58K
23:00 UTC-2%52K
Engagement by day of weekSeven bars, one per weekday, Sunday first. Each bar shows how posts published on that day compare with their own authors' median engagement. Bars above the centre line ran higher than the median, bars below ran lower. A marker flags Busiest day: Thursday.
SunMonTueWedThuFriSat
Above the authors' own mediansBelowScale: plus or minus 5%Busiest day: Thursday
Show engagement by day of week as a table
Engagement by day of week
DayVs author medianPosts
Sunday+4%232K
Monday0%290K
Tuesday-2%281K
Wednesday-1%252K
Thursday-2%245K
Friday-3%254K
Saturday+3%228K
See what moves engagement across the whole catalogWhat counts as a good engagement rate at this size

Best tweets

  • Oct 19, 202530x their median

    Well, this is interesting. Our Native American friends are saying the quiet part out loud. https://t.co/bRZkTTCu3M

    31K11K621666796K viewsView on X
  • Aug 6, 202612x their median

    A government that can tell your doctor what he's allowed to say can tell your doctor to lie to you. Yesterday, a federal judge told California it can't do that anymore. Four years. We sued. We won. Free speech prevailed. Full story below👇 https://t.co/q6CFUB6WxH

    13K4.2K373201482K viewsView on X
  • Dec 8, 202510x their median

    Did you know the news used to regularly air stories about people's lives being ruined by vaccines? That all changed after Clinton let Pharma buy out the media. Here I compiled 56 mind-blowing news segments they'd never air today. https://t.co/HI2GyO0M1R

    10K4.4K113130427K viewsView on X
  • Nov 2, 20255.6x their median

    When SSRIs came out, the FDA was deluged with reports of suicide, homicide and mass shootings caused by those "antidepressants." Lawsuits then revealed the industry knew that risk, but, just like now, the FDA hid it from the public. This 1991 FDA hearing will blow you mind as many of these stories should have been immediate grounds to take SSRIs off the market-but instead more and more people keep getting put onto them. In this thread I'll show the suppressed data on the real dangers of SSRIs they keep covering up and never tell you about when you start the drugs.🧵

    5.6K2.2K13299728K viewsView on X
  • Oct 7, 20255.6x their median

    FDA Director Marks just became a multimillion Pharma executive. He: •Approved the COVID vax without letting the FDA review it by removing the FDA's top vaccine experts •Buried every injury but told us it was "safe" Here I show what Peter did to America https://t.co/DqRDmn6NXi

    5.1K2.7K206106185K viewsView on X
  • May 8, 20262.9x their median

    Pierre Kory: Ivermectin, Senate Testimony, & The Cost of Dissent | My Price Is My Life Ep. #27 In Episode 27 of My Price Is My Life, James O’Keefe interviews Pierre Kory (@PierreKory ), a critical care physician and pulmonary specialist who became one of the most controversial voices in America during the COVID-19 pandemic. Dr. Kory discusses his medical career before the pandemic, the chaos inside overwhelmed hospitals during COVID-19, and the moment he began publicly advocating for ivermectin as a treatment. He reflects on his 2020 Senate testimony, which thrust him into the center of a national debate over medicine, censorship, and institutional authority. The conversation explores the backlash that followed, including opposition from major health agencies and pharmaceutical companies, the rise of the FLCCC Alliance, and the growing divide between frontline physicians and the medical establishment throughout the pandemic. Listen & Subscribe to My Price Is My Life Website: https://t.co/RA9FMVcVBe Spotify: https://t.co/LK9rnpklWr Apple Podcasts: https://t.co/BmXWimwyxE American Swiper Series: Unlock never before seen undercover footage. Subscribe to https://t.co/yT6SDuM5DX

    2.9K1.2K892488K viewsView on X
  • Aug 13, 20262.8x their median

    An Important Win! The FDA No Longer Claims That Chlorine Dioxide Is Unsafe... The Warning Pages Have Been Removed And Deleted From Their Website. This is no small shift. It is a clear turning point. From today on, when people bring up Chlorine Dioxide, they can no longer use safety concerns as a default dismissal. The Diverse Ecosystem of Chlorine Dioxide Therapies: Oral ingestion: Often promoted by grassroots communities as a universal detoxifier, with treatment claims in infectious disease, cancer, and autism. Topical application & sprays: Used for wounds, skin infections, oral/throat conditions, and nasal/sinus conditions. Nebulized or vapor therapies: Applied in respiratory conditions like COVID-19 or asthma, often self-administered. Intravenous (IV): A more recent and highly controversial direction. Notably, a U.S.-based company has already developed and tested intravenous Chlorine Dioxide under the name NP001 for ALS. Intratumoral injection: A new field of study and invention. The ability of Chlorine Dioxide to induce tumor necrosis through direct injection, with rapid and localized results in advanced solid tumors.

    2.7K1.1K8375176K viewsView on X
  • Nov 19, 20252.6x their median

    Sam Harris blames Joe Rogan and “Ivermectin cultists” for creating a “polluted information landscape” during COVID https://t.co/CyDdvbcN8N

    2.0K2331.3K2021.6M viewsView on X
  • Oct 13, 20252.4x their median

    Retrospective studies showing vaccinated kids are much sicker are always dismissed for not being "well-controlled." According to evidence based medicine, the "best available evidence" should guide clinical decisions. Since placebo trials on vaccines are never done for "ethical" reasons, by the rules of evidence based medicine, the retrospective studies we have are the "best available evidence" and their conclusions about vaccine harm cannot be dismissed unless better (placebo controlled trials) are conducted to corroborate or refute them. The vaccine safety community's perspective is that the actual reason those placebo trials are never done is because they would immediately show how dangerous the vaccines are---hence why the vaccine industry has to constantly make excuses for not doing them while simultaneously claiming if done they would show vaccines are harmless. In short, anytime someone critiques a retrospective study comparing vaccinated to unvaccinated as "invalid" it's critical to remember those studies are the gold standard because "better" ones will never be done.

    2.6K6958837186K viewsView on X
  • Feb 10, 20261.9x their median

    The National Cancer Institute is studying ivermectin as a potential cancer treatment, according to its top official, alarming career scientists. https://t.co/Wuu8NLDIzE

    1.8K555171192809K viewsView on X

Ranked by total interactions across everything we have tracked for this account, which is a longer history than the 30-day window the rates above use. The multiple compares each post to this account's own median.

Buy or sell X accounts - escrow-protected

PlayerSells is an escrow marketplace for X accounts. Every deal is protected, with no middleman risk.

Reading these numbers

A typical post picks up 1.4K interactions against 612K followers, an engagement rate of 0.236%. Posts are seen about 59K times each, and 2.47% of those impressions turn into an interaction. That is about 9.57% of the follower count, which is the gap between an audience on paper and an audience in a timeline. Posting runs at about 0.3 posts a day over the last 30 days, though only 20% of days saw any activity at all. Most posts go out around 02:00 UTC, and Thursday is the busiest day of the week. Of the 5 posts sampled, 40% carry an image or video and 60% link out. The account's strongest tracked post pulled 44K interactions, about 30x its own typical post. Only 5 original posts have been captured so far, fewer than the 8 posts we want behind a median before treating it as settled. Read the figures above as an early measurement of this account, not as a finished profile of it.

What is Pierre Kory, MD MPA's engagement rate on X?
Pierre Kory, MD MPA (@PierreKory) has an engagement rate of 0.236%, based on the median interactions across 5 original posts from the last 30 days against 611,898 followers. Replies, reposts and quote-posts of other people are excluded from that sample.
Is that a good engagement rate?
At 0.236%, Pierre Kory, MD MPA sits above the 50th percentile of the 36,852 accounts in this comparison. Those comparison accounts are all large ones, because our scanning cadence is weighted towards big accounts, so this is a ranking among peers of similar scale rather than a ranking across X.
Does @PierreKory have real engagement?
There is not yet enough sample to rank this account against others of its size.
When does @PierreKory post?
Most posts go out around 02:00 UTC, and Thursday is its busiest day, at roughly 0.3 posts per day across the measured window.

Keep going